ArticleMedicine2020

Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.

Chunhoo Cheon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.